US Stock Market Move | Odyssey Therapeutics (ODTX.US) debuts on the US stock market, with minimal fluctuations in the opening stock price.
As of press time, the stock has fallen more than 1%, to $17.81.
On Friday, Odyssey Therapeutics (ODTX.US) debuted on the US stock market with an IPO price of $18. The stock opened with little fluctuation and by the time of writing, it had dropped more than 1% to $17.81. Odyssey Therapeutics is a clinical-stage biotechnology company based in Boston, focusing on the research and development of drugs for autoimmune and inflammatory diseases. The company's core product is OD-001, a small molecule drug for the treatment of ulcerative colitis, which is currently in mid-stage clinical trials. In addition, the company has pipelines for other immune diseases such as lupus and atopic dermatitis.
Related Articles
US Stock Market Move | Mobia Medical (MOBI.US) debuts on the US stock market with an 18% decline at the opening.
US Stock Market Move | Qualcomm (QCOM.US) soared more than 11% in early trading, with a cumulative increase of 75% since April.
US Stock Market Move | Q2 guidance is low, "NVIDIA Corporation's favorite child" CoreWeave (CRWV.US) falls more than 11% in early trading.
US Stock Market Move | Mobia Medical (MOBI.US) debuts on the US stock market with an 18% decline at the opening.
US Stock Market Move | Qualcomm (QCOM.US) soared more than 11% in early trading, with a cumulative increase of 75% since April.
US Stock Market Move | Q2 guidance is low, "NVIDIA Corporation's favorite child" CoreWeave (CRWV.US) falls more than 11% in early trading.
